Cardiologs Holter Platform vs iPredict Eye Screening
AI Verdict
Choose Cardiologs Holter Platform if…
Choose the Cardiologs Holter Platform if your practice primarily focuses on comprehensive and efficient cardiac arrhythmia detection and analysis using Holter ECG data. This AI-powered, cloud-based solution is ideal for cardiologists and healthcare professionals seeking to reduce Holter analysis time by approximately 42% and accurately detect over 20 types of arrhythmias, integrating seamlessly with existing EMR systems. It's particularly well-suited for environments needing vendor-neutral compatibility with various Holter devices and secure, anytime, anywhere access to analysis results.
View Cardiologs Holter Platform →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your healthcare setting aims to offer early, AI-powered screening for multiple prevalent eye diseases and systemic health risks, particularly in primary care. This tool is best for practices looking to screen patients aged 50 and older for age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, with results available in under 60 seconds. It also provides valuable risk prediction for systemic conditions like stroke and heart attack, making it suitable for a holistic patient assessment in a quick and non-invasive manner.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiologs Holter Platform | iPredict Eye Screening |
|---|---|---|
| Pricing | Contact sales | Contact for pricing |
| Deployment | Cloud-based (SaaS) | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iPredict Eye ScreeningiPredict Eye Screening emphasizes ease of operation with a non-invasive, advanced touchscreen interface and a quick test completion time of under 5 minutes, generating reports in under 60 seconds. Cardiologs Holter Platform, while cloud-based and offering remote access, focuses more on reducing analysis time for professionals rather than the patient-facing ease of use.
Clinical Value
iPredict Eye ScreeningiPredict Eye Screening offers screening for multiple critical conditions (Diabetic Retinopathy, AMD, Glaucoma) and provides risk prediction for systemic diseases like stroke and heart attack, broadening its clinical utility. Cardiologs Holter Platform focuses solely on detecting over 20 types of arrhythmias from ECG data. While both are FDA-cleared, iPredict's multi-disease screening and risk prediction offer a wider range of clinical applications.
Pricing & Value
iPredict Eye ScreeningiPredict Eye Screening provides an estimated per-patient screening cost ($10-$20), offering some transparency and a clear value proposition tied to Medicare/commercial payor reimbursement. Cardiologs Holter Platform states 'contact sales' for pricing and 'pay per ECG regardless the number of users,' which is less transparent and makes direct value comparison difficult without further inquiry.
Enterprise Readiness
Cardiologs Holter PlatformCardiologs Holter Platform explicitly highlights vendor-neutral compatibility with multiple Holter devices and integration with EMR systems (Philips IntelliBridge Enterprise), indicating strong enterprise readiness. While iPredict Eye Screening mentions EHR integration and telemedicine services, it does not detail the breadth of its compatibility or specific enterprise-level features as extensively as Cardiologs.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. Cardiologs Holter Platform leverages deep learning AI for comprehensive ECG analysis and was the first FDA-cleared AI solution for ECG analysis. iPredict Eye Screening utilizes AI for automated screening of multiple retinal diseases and risk prediction for systemic conditions, also being the first to seek FDA clearance for AMD screening. Their innovative approaches are tailored to different medical specialties, making it difficult to declare one definitively more innovative than the other overall.
Support & Docs
Cardiologs Holter PlatformCardiologs Holter Platform, being a Philips product, benefits from Philips' established infrastructure, mentioning 'Award-winning services delivered in ways that promote your clinical, operational and technical success, including enterprise-level support' and easily accessible technical support. iPredict Eye Screening does not explicitly detail its support and documentation offerings in the provided information, making Cardiologs appear more robust in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiologs Holter Platform | iPredict Eye Screening |
|---|---|---|
| Name | Cardiologs Holter Platform | iPredict Eye Screening |
| Company | Philips France Commercial | iHealthScreen |
| Description | The Cardiologs Holter Platform by Philips is an AI-powered, cloud-based solution for fast and accurate Holter ECG analysis, designed to detect over 20 types of arrhythmias and streamline cardiac diagnostics for healthcare professionals. | iHealthScreen offers an FDA-cleared AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services. |
| Categories | Cardiology AI | Cardiology AI, Neurology AI, Ophthalmology AI |
| Specialties | Cardiology | Family Medicine, Internal Medicine, Ophthalmology |
Videos
Demos, reviews, and walkthroughs featuring Cardiologs Holter Platform and iPredict Eye Screening.